N
CTXR icon

Nuveen’s Citius Pharmaceuticals CTXR Stock Holding History

Nuveen’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,386
Closed -$435K – 3352
2024
Q1 		$435K Hold
19,386
– – ﹤0.01% 3017
2023
Q4 		$367K Hold
19,386
– – ﹤0.01% 3101
2023
Q3 		$332K Hold
19,386
– – ﹤0.01% 2946
2023
Q2 		$582K Buy
+19,386
New +$638K ﹤0.01% 2877
2022
Q2 		– Sell
-17,852
Closed -$795K – 3297
2022
Q1 		$795K Buy
17,852
+161
+0.9% +$6.36K ﹤0.01% 2884
2021
Q4 		$701K Sell
17,691
-1,520
-8% -$69K ﹤0.01% 2974
2021
Q3 		$999K Sell
19,211
-157
-0.8% -$7.88K ﹤0.01% 2986
2021
Q2 		$1.69M Buy
+19,368
New +$1.16M ﹤0.01% 2788

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's CTXR Position: Q2 2024 in Review

Nuveen sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 19,386 shares — an estimated $435K sold.

Nuveen first reported a position in CTXR in Q2 2021 and held it in 8 quarters. The position peaked at $1.69M in Q2 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • Nuveen reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 19,386 Citius Pharmaceuticals shares in Q2 2024, an estimated $435K.
  • Nuveen first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Nuveen's Citius Pharmaceuticals position peaked at $1.69M in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.